DK0782569T3 - Racemiseringsfremgangsmåde anvendt ved fremstilling af levobupivacain og analoger deraf - Google Patents

Racemiseringsfremgangsmåde anvendt ved fremstilling af levobupivacain og analoger deraf

Info

Publication number
DK0782569T3
DK0782569T3 DK95932092T DK95932092T DK0782569T3 DK 0782569 T3 DK0782569 T3 DK 0782569T3 DK 95932092 T DK95932092 T DK 95932092T DK 95932092 T DK95932092 T DK 95932092T DK 0782569 T3 DK0782569 T3 DK 0782569T3
Authority
DK
Denmark
Prior art keywords
pct
compound
levobupivacaine
analogs
preparation
Prior art date
Application number
DK95932092T
Other languages
English (en)
Inventor
Ulrich Conrad Dyer
Christopher James Lock
Martin Woods
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9504927.6A external-priority patent/GB9504927D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of DK0782569T3 publication Critical patent/DK0782569T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of Radiation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK95932092T 1994-09-23 1995-09-22 Racemiseringsfremgangsmåde anvendt ved fremstilling af levobupivacain og analoger deraf DK0782569T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94306962 1994-09-23
GBGB9504927.6A GB9504927D0 (en) 1995-03-10 1995-03-10 Racemisation and asymmetric transformation
PCT/GB1995/002247 WO1996009290A1 (en) 1994-09-23 1995-09-22 Racemisation and asymmetric transformation processes used in the manufacture of levobupivacaine and analogues thereof

Publications (1)

Publication Number Publication Date
DK0782569T3 true DK0782569T3 (da) 2002-07-22

Family

ID=26137306

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95932092T DK0782569T3 (da) 1994-09-23 1995-09-22 Racemiseringsfremgangsmåde anvendt ved fremstilling af levobupivacain og analoger deraf

Country Status (18)

Country Link
US (1) US5786484A (da)
EP (1) EP0782569B1 (da)
JP (1) JP3898220B2 (da)
KR (1) KR100393133B1 (da)
CN (1) CN1104416C (da)
AT (1) ATE214695T1 (da)
AU (1) AU695479B2 (da)
CA (1) CA2200490C (da)
DE (1) DE69525950T2 (da)
DK (1) DK0782569T3 (da)
ES (1) ES2173194T3 (da)
FI (1) FI117436B (da)
HU (1) HU216291B (da)
MX (1) MX9702210A (da)
NO (1) NO308074B1 (da)
PL (1) PL183204B1 (da)
PT (1) PT782569E (da)
WO (1) WO1996009290A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6384227B2 (en) 1995-01-18 2002-05-07 Darwin Discovery Ltd. Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
JP2000256359A (ja) * 1999-03-11 2000-09-19 Japan Science & Technology Corp 面性キラリティーを有する分子群の高選択的不斉変換法
US6288280B1 (en) * 1999-07-09 2001-09-11 Hoffmann-La Roche Inc. Racemization of atropisomeric bis(phosphine oxide) compounds
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US6962998B2 (en) 2000-06-14 2005-11-08 Toray Industries, Inc. Processes for producing racemic piperidine derivative and for producing optically active piperidine derivative
DE10029851A1 (de) * 2000-06-16 2001-12-20 Boehringer Ingelheim Pharma Enantiomerentrennung von Piperidon-Derivaten unter gleichzeitiger in situ Racemisierung des unerwünschten Enantiomers
US6495694B2 (en) 2000-06-16 2002-12-17 Boehringer Ingelheim Pharma Kg Efficient separation of enantiomers of piperidone derivatives by precipitation of the desired eantiomer during in situ racemization of the unwanted enantiomer
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
SI1575569T1 (sl) 2002-12-13 2010-12-31 Durect Corp Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
EP2415484B1 (en) 2004-09-17 2014-06-18 Durect Corporation Sustained local anesthetic composition containing SAIB
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
CA2706931C (en) * 2007-12-06 2015-05-12 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) * 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
EP2983468A4 (en) 2013-03-15 2016-09-07 Durect Corp COMPOSITIONS WITH RHEOLOGY MODIFIER TO REDUCE RESOLUTION VARIABILITY
CN103664744B (zh) * 2013-11-30 2015-07-15 山东永泰化工有限公司 一种左布比卡因的制备方法
KR20210039987A (ko) * 2018-05-18 2021-04-12 쿠라 온콜로지, 인크. 티피파닙의 합성
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Also Published As

Publication number Publication date
EP0782569B1 (en) 2002-03-20
MX9702210A (es) 1998-05-31
PL183204B1 (pl) 2002-06-28
DE69525950D1 (de) 2002-04-25
KR100393133B1 (ko) 2003-11-17
NO308074B1 (no) 2000-07-17
CA2200490C (en) 2007-01-09
CN1159184A (zh) 1997-09-10
DE69525950T2 (de) 2002-09-19
US5786484A (en) 1998-07-28
EP0782569A1 (en) 1997-07-09
CA2200490A1 (en) 1996-03-28
FI971202A0 (fi) 1997-03-21
JPH10505855A (ja) 1998-06-09
NO971358D0 (no) 1997-03-21
HU216291B (hu) 1999-06-28
ES2173194T3 (es) 2002-10-16
FI971202A (fi) 1997-03-21
CN1104416C (zh) 2003-04-02
AU3527995A (en) 1996-04-09
PT782569E (pt) 2002-09-30
AU695479B2 (en) 1998-08-13
PL319368A1 (en) 1997-08-04
NO971358L (no) 1997-03-21
ATE214695T1 (de) 2002-04-15
JP3898220B2 (ja) 2007-03-28
HUT77055A (hu) 1998-03-02
WO1996009290A1 (en) 1996-03-28
FI117436B (fi) 2006-10-13

Similar Documents

Publication Publication Date Title
DK0782569T3 (da) Racemiseringsfremgangsmåde anvendt ved fremstilling af levobupivacain og analoger deraf
DK0788481T3 (da) Fremgangsmåde til fremstilling af levobupivacain og analoger deraf
DE59607490D1 (de) Verfahren zur herstellung von wirkstoffzubereitungen in form einer festen lösung des wirkstoffs in einer polymermatrix
NO964346D0 (no) Fremgangsmåte for opplösning av Etodolac ved bruk av glukaminderivater
DK0790824T3 (da) 2,2-dichloralkancarboxylsyrer, fremgangsmåde til fremstilling deraf, lægemidler indeholdende disse og anvendelse af disse lægemidler til behandling af insulinresistens
NO971903L (no) Krystallisering av levobupivacain og analoger derav
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69824839D1 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5-halogen-pyridinen, verwendbar als cox-2 inhibitoren
ATE111455T1 (de) 3-substituierte 1,2,3,4-oxatriazol-5- iminderivate, verfahren zur herstellung sowie diese enthaltende arzneimittel.
SE9501808D0 (sv) New process
ATE397088T1 (de) Verfahren zur herstellung von (s)- oder (r)-3,3,3-trifluor-2-hydroxy-2-methylpropionsaü e
DE69713163D1 (de) Verfahren zur herstellung von enantiomerisch angereicherten n-acylazetidin-2-carbonsäuren
DK0808306T3 (da) Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
DK0784603T3 (da) Racemisering af forstadier for levobupivacain og analoge forstadier heraf
ATE421953T1 (de) Verfahren zur racemisierung von 1-benzyl-4-(4- fluorophenyl)-3-hydroxymethyl-1,2,3,6- tetrahydropyridin und dessen verwendung in der synthese von paroxetin
DE59604890D1 (de) Verfahren zur racemattrennung von 2-aryl-2-alkyl-omega-alkylamino-alkannitrilen
DK440088D0 (da) Fremgangsmaade til fremstilling af n6-benzyloxycarbonyl-2,6-diaminopimelamsyre